NEW YORK (GenomeWeb) – ID Genomics said today that it has formed a national consortium of clinical partners with the objective of improving the speed and accuracy of infectious disease diagnostics and antibiotic treatment.

The firm will work with partners in the consortium to record genetic fingerprints of antibiotic strains isolated from patients with active infections, and to characterize the strains' antibiotic susceptibility.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.